Daiwa Securities Group Inc. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$3
-25.0%
1,6100.0%0.00%
Q2 2023$4
+33.3%
1,6100.0%0.00%
Q1 2023$3
-62.5%
1,6100.0%0.00%
Q4 2022$8
-99.9%
1,610
+8.6%
0.00%
Q3 2022$7,000
-92.6%
1,483
-94.2%
0.00%
-100.0%
Q2 2022$95,000
-24.6%
25,589
+14.1%
0.00%0.0%
Q1 2022$126,000
+31.2%
22,432
+42.4%
0.00%0.0%
Q4 2021$96,000
+68.4%
15,756
+170.7%
0.00%
Q3 2021$57,000
+418.2%
5,820
+680.2%
0.00%
Q2 2021$11,000
+120.0%
746
+245.4%
0.00%
Q1 2021$5,0002160.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders